CCO Conference Highlights from the 2020 ESMO Virtual Congress

September 19-21, 2020; Virtual Conference
Download this summary slideset that includes key data from studies in breast, lung, genitourinary, and gastrointestinal cancers presented at the 2020 ESMO Virtual Congress.
Yelena Y. Janjigian, MD
Joyce O'Shaughnessy, MD
Elizabeth R. Plimack, MD, MS
person default
Vamsidhar Velcheti, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 1.86 MB
Released: October 23, 2020

Acknowledgements

Supported by an educational grant from
Bristol-Myers Squibb

Related Content

Updated data from the CheckMate 648 study of first-line nivolumab + either chemotherapy or ipilimumab for esophageal SCC, presented at ASCO GI 2023 and reported by Clinical Care Options (CCO)

Released: February 2, 2023

Read expert advice about the importance of managing adjuvant abemaciclib adverse events in early breast cancer, from Clinical Care Options (CCO)

Julia LaBarbera, MSN, RN, AGACNP-BC Released: January 31, 2023

Mark Pegram, MD, and Sara Tolaney, MD, MPH, discuss treatment and optimal management approaches for patients with TNBC, from Clinical Care Options (CCO)

Mark Pegram, MD Sara Tolaney, MD, MPH Released: January 31, 2023

Phase II trial evaluating pemigatinib for previously treated mCRC with FGF/FGFR alterations, presented at ASCO GI 2023 and reported by Clinical Care Options (CCO)

Released: January 30, 2023

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings